Ahlcon Parenterals (India) Peer Comparison

BSE: 524448

₹515.00

₹-1.00 (-0.19%)

As on 21-Jan-2015IST

Market cap

₹371 Cr

Revenue (TTM)

₹176 Cr

P/E Ratio

--

P/B Ratio

4.3

Div. Yield

0 %

Edit

	Ahlcon Parenterals (India)	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Market cap (₹ Cr)	371	35,842	28,803	28,371	28,458
Revenue (₹ Cr)	176	3,564	1,936	1,462	9,205
Net Profit (₹ Cr)	-19.79	414.00	288.22	387.35	-371.81
Net Margin (%)	-10.98	11.23	14.79	26.01	-3.93
RoE (%)	--	8.38	29.77	25.18	-3.85
Price to Earnings	--	87.63	99.93	73.46	--
Price-To-Book	4.31	7.12	21.46	16.44	3.55

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Ahlcon Parenterals (India)	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Operating Revenue	175.67	3,230.00	313.57	520.14	6,559.10
Total Income	180.27	3,250.00	330.42	522.90	6,834.90
Total Expenditure	148.96	2,932.00	352.80	414.96	5,609.44
EBITDA	26.70	298.00	-39.23	105.18	949.66
Depreciation	25.47	247.00	34.01	10.08	586.18
EBIT	1.23	51.00	-73.24	95.10	363.48
Interest	25.63	299.00	9.72	6.41	198.25
Other Income	4.61	20.00	16.85	2.76	275.80
Exceptional Items	--	-183.00	--	--	-15.08
Profit before Tax	-19.79	-411.00	-66.11	91.45	484.98
Provision for Tax	--	-132.00	1.01	19.50	109.02
Profit after Tax	-19.79	-279.00	-67.12	71.95	375.96

Liabilities (₹ Cr)

	Ahlcon Parenterals (India)	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Shareholder's Funds	-115.93	3,849.00	305.40	522.27	6,696.60
Minority Interest	--	353.00	--	--	--
Non-Current Liabilities	259.01	261.00	70.61	7.29	2,902.58
Current Liabilities	131.92	3,207.00	183.51	129.32	3,118.01
Total Liabilities	275.00	8,215.00	559.52	658.88	12,822.45

Assets (₹ Cr)

	Ahlcon Parenterals (India)	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Non-Current Assets	205.21	5,081.00	231.12	229.31	8,565.30
Current Assets	69.79	2,445.00	328.40	429.57	4,151.89
Total Assets	275.00	8,215.00	559.52	658.88	12,822.45
Total Debt*	339.30	1,862.00	169.56	0.84	4,023.28
Net Current Assets	-62.13	-762.00	144.89	300.25	1,033.88
Contingent Liabilities	7.74	840.00	2.01	2.70	44.94

Cashflow (₹ Cr)

	Ahlcon Parenterals (India)	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Cash From Operating Activities	11.47	413.00	-62.63	-11.93	766.42
Cash Flow from Investing Activities	-3.68	-201.00	-54.92	-120.72	-1,812.10
Cash from Financing Activities	7.07	-71.00	63.05	140.26	794.19
Net Cash Inflow / Outflow	14.86	141.00	-54.50	7.61	-251.49

Ratios

Profitability Ratios

	Ahlcon Parenterals (India)	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
ROCE (%)	2.65	-1.96	-11.97	23.85	7.10
ROE (%)	0.00	-7.77	-20.49	21.07	6.11
ROA (%)	-7.33	-3.71	-12.23	13.42	3.20
EBIT Margin (%)	17.82	9.85	-7.14	20.75	18.68
Net Margin (%)	-10.98	-8.58	-20.31	13.76	5.50
Cash Profit Margin (%)	3.24	-0.62	-10.56	15.77	13.17

Growth Ratios

	Ahlcon Parenterals (India)	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Revenue Growth (%)	32.77	19.28	-0.37	52.71	3.87
EBIT Growth (%)	436.96	360.87	-121.99	32.39	-23.03
Net Profit Growth (%)	57.93	6.06	-318.70	33.24	-54.98
EPS Growth (%)	57.93	-129.48	-318.70	245.55	-62.24
Book Value Growth (%)	-20.58	14.43	-19.00	224.94	19.48

Valuation Ratios

	Ahlcon Parenterals (India)	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Price / Earnings	0.00	0.00	0.00	50.63	0.00
Price / Book Value	0.00	0.99	0.00	6.97	0.00
Dividend Yield (%)	--	0.00	--	0.30	--
EV/EBITDA	10.58	16.52	-5.45	32.83	3.98
Market Cap (₹ Cr)	0.00	3,798.72	0.00	3,642.45	0.00

Solvency Ratios

	Ahlcon Parenterals (India)	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Debt to Equity	-2.93	0.49	0.58	0.00	0.60
Short term debt to equity ratio	-0.74	0.27	0.30	--	0.10
Current Ratio	0.53	0.76	1.79	3.32	1.33
Quick Ratio	0.33	0.52	1.30	2.45	0.89
Interest Coverage	0.23	-0.37	-5.80	15.27	3.45

Operating Efficiency Ratios

	Ahlcon Parenterals (India)	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Debtors to sales (%)	13.82	28.42	44.51	31.47	27.22
Asset Turnover	0.65	0.68	0.57	0.97	0.62
Receivable days	40.71	65.29	160.50	99.79	83.94
Inventory Days	47.02	55.76	88.37	60.54	65.47
Payable days	58.67	232.91	252.95	135.92	144.76
Cash Conversion Cycle	29.05	-111.86	-4.08	24.41	4.65

Annual
Quarterly